Opinion

Medimpact Healthcare Systems, Inc. v. IQVIA Holdings Inc.

Court
District Court, S.D. California
Filed
May 26, 2022
Cited by
0 cases

The opinion

1

2

3

4

5

6

7

8 UNITED STATES DISTRICT COURT

9 SOUTHERN DISTRICT OF CALIFORNIA

10

11 MEDIMPACT HEALTHCARE Case No.: 19-cv-1865-GPC-DEB

SYSTEMS, INC., et al.,

12

ORDER:

Plaintiffs,

13 (1) GRANTING IN PART AND

v. DENYING IN PART DEFENDANTS’

14

MOTION TO COMPEL; AND

IQVIA INC., et al.,

15 (2) GRANTING DEFENDANTS’

Defendants. MOTION TO FILE DOCUMENTS

16

UNDER SEAL

17

[DKT. NOS. 531, 533]

18

19 I. INTRODUCTION

20 Before the Court is Defendants’ Motion to Compel Rule 30(b)(6) Discovery. Dkt.

21 No. 533. The Motion seeks to compel: (1) deposition testimony on Topic 4 of Defendants’

22 Rule 30(b)(6) notice dated March 15, 2022 (relating to Plaintiffs’ policies and practices for

23 retention of electronically stored information (“ESI”)); and (2) Plaintiffs’ unredacted

24 litigation holds. Defendants contend changed circumstances have placed Plaintiffs’ ESI

25 retention policies and practices into question. Plaintiffs’ respond that these disputes are

26 untimely, there is no good cause to reopen discovery, and their litigation holds are

27 privileged. Dkt. No. 546. For the reasons discussed below, the Court grants, in part,

28

1 Defendants’ Motion regarding Topic 4 and denies Defendants’ Motion to compel

2 production of Plaintiffs’ unredacted litigation holds.

3 II. RELEVANT FACTUAL BACKGROUND

4 Fact discovery in this case closed on October 8, 2021, and expert discovery closed

5 on January 21, 2022. Dkt. No. 255. During discovery, Defendants received inconsistent

6 and/or uncertain information about Plaintiffs’ ESI retention policy and litigation holds.

7 Plaintiffs’ CFO, James Gollaher, and Plaintiffs’ in-house counsel, Aaron Roberts,

8 testified about Plaintiffs’ ESI policies and procedures. Gollaher testified Plaintiffs

9 and Roberts testified there may be a “

10 ” Plaintiffs’ employees “ ” Dkt. Nos. 532-4 at 6; 532-5 at 5

11 (sealed).1 Dale Brown, Plaintiffs’ designated Rule 30(b)(6) witness on Plaintiffs’

12 “document retention policies, procedures, and practices” (Dkt. Nos. 546-2 at 13; 546-3 at

13 13; 546-4 at 13”), testified, however, that “MedImpact has preserved all e-mails of the

14 company . . . .” Dkt. No. 546-5 at 7. But Brown did not know whether Plaintiffs’ ESI

15 preservation policies were documented or how long they have been in place. Dkt. No. 532-

16 3 at 8–9 (sealed).

17 Brown also testified that Plaintiffs did not issue a litigation hold in this case. Id.at 4–

18 5 (sealed). On March 3, 2022 (after fact discovery closed), however, Brown submitted a

19 declaration correcting this testimony and stating Plaintiffs had, in fact, issued a litigation

20 hold. See Dkt. No. 532-6 ¶ 4 (sealed) (“

21 . . . .”). In that same declaration, Brown also stated:

22 (1) Plaintiffs’ preservation practice is to “ ”; and

23 (2) Plaintiffs’ “

24 .” Id. ¶¶ 8, 10 (sealed).

25

26

27

1 When referencing page numbers for documents filed with the Court, the Court’s citation

28

1 Separately, Defendants identified and requested that Plaintiffs produce emails

2 missing from Plaintiffs’ responses to Defendants’ Requests for Production of Documents.

3 Dkt. No. 532-7 (sealed). On January 27, 2022 (also after fact discovery closed), Plaintiffs

4 responded six of the

5 Id. at 3–4 (sealed).

6 Following Brown’s March 3, 2022 declaration, Defendants’ served a Rule 30(b)(6)

7 notice on Plaintiffs seeking testimony on four topics:

8

1. The March 3, 2022 Declaration of Dale Brown Regarding

9 Litigation Hold Memo and Instructions.

10

2. The litigation hold issued in connection with the above

11 captioned case, and the circumstances surrounding its

issuance, including, without limitation, to whom it was issued

12

and when, how it was issued, and why it was issued to each

13 recipient at the time that it was.

14 3. The litigation hold issued in connection with MedImpact

15 International LLC, et al. v. Dimensions Healthcare LLC, et

al., DIFC-LCIA Arbitration No: DC18141, and the

16 circumstances surrounding its issuance and duration,

17 including, without limitation, to whom it was issued and

when, how it was issued, why it was issued to each recipient

18 at the time that it was, and how long it remained in effect.

19

4. MedImpact’s retention and preservation of electronic data,

20 including how and where MedImpact retains and preserves

electronic data; the sources of electronic data from which

21

MedImpact searched and collected documents in connection

22 with the above captioned case; the ability of MedImpact

employees to delete, modify or remove electronic data; and

23

any restrictions implemented by MedImpact or imposed upon

24 MedImpact employees to restrict their ability to delete,

modify or remove electronic data.

25

26 Dkt. No. 533-3 at 4–5.

27 / /

28 / /

1 The deposition notice also included two document requests:

2

1. The litigation hold issued in connection with the above

3 captioned case.

4

2. The litigation hold issued in connection with MedImpact

5 International LLC, et al. v. Dimensions Healthcare LLC, et

al., DIFC-LCIA Arbitration No: DC18141.

6

7 Id. at 5.

8 The Court held a discovery conference after Plaintiffs objected to Defendants’

9 discovery requests. Dkt. No. 501. Following the discovery conference, Plaintiffs agreed to

10 produce a witness on Topics 1, 2, and 3. But, Plaintiffs refused to produce a witness on

11 Topic 4. Plaintiffs also refused to produce unredacted copies of their litigation holds,

12 asserting they are protected by the attorney-client privilege and are work product. This

13 Motion followed.

14 III. DISCUSSION

15 For the reasons discussed below, the Court finds good cause for Defendants to take

16 limited deposition testimony on Topic 4. The Court also finds Defendants have not made

17 a sufficient showing to overcome Plaintiffs’ attorney-client privilege for the redacted

18 litigation holds.

19 A. Topic 4

20 Defendants seek testimony on Topic 4 to further explore Plaintiffs’ ESI policies and

21 procedures. Dkt. No. 533-1 at 10. This testimony is appropriate given the uncertainties

22 surrounding: (1) whether Plaintiffs initiated a litigation hold in this case; and (2) Plaintiffs’

23 ESI retention policy and procedures. Brown originally testified Plaintiffs did not issue a

24 litigation hold in this case. Dkt. No. 532-2 at 4 (sealed). On March 3, 2022, however,

25 Brown signed a declaration stating, although he “

26

27 .” Dkt. No. 532-6 ¶¶ 3, 4 (sealed).

28

1 Plaintiffs filed this case in September 2019 – more than one year before it issued the

2 litigation hold described by Brown. Dkt. No. 1. This one-year delay raises a legitimate

3 question whether anything was lost, discarded, or destroyed in the interim. That question,

4 in turn, implicates Plaintiffs’ claim that they permanently preserve all electronic data.

5 Dkt. No. 546 at 11.

6 Defendants also establish some uncertainty exists on Plaintiffs’ preservation of

7 electronic data. Although Brown maintained “

8 ,” Dkt. No. 532-6 ¶ 10 (sealed), other witnesses have not testified as

9 definitively. For example, although not Rule 30(b)(6) witnesses, Plaintiffs’ CFO Gollaher

10 testified MedImpact has a “ ,” Dkt. No. 532-

11 5 at 5 (sealed) (emphasis added). Plaintiffs’ in-house counsel Roberts testified he believes

12 there is “ ” Plaintiffs’ employees “

13 ”. Dkt. No. 532-4 at 6 (sealed). And Brown himself originally testified

14 he did not know when this no-destruction policy started. Dkt. No. 532 at 8–9 (sealed).

15 Plaintiffs’ January 27, 2022 response that six emails specifically requested by

16 Defendants Dkt. No. 532-7 at 3–4 (sealed),

17 gives Defendants further cause to inquire into Plaintiffs’ ESI retention policies and

18 procedures.2

19 For these reasons, the Court rules Defendants’ Topic 4 is a relevant and appropriate

20 topic for supplemental discovery. See Brewer v. BNSF Ry. Co., No. 14-cv-00065-GF-

21 BMM-JTJ, 2018 WL 882812, at *2 (D. Mont. Feb. 14, 2018) (“A party should not be

22 required to provide discovery about its e-discovery without good cause. . . . A party seeking

23 discovery on discovery must show a specific deficiency in the other party’s production.”)

24

25

2 The Court is making no finding that Plaintiffs lost or destroyed any relevant discovery.

26

The Court also understands Gollaher’s and Roberts’ testimony and the unavailability of the

27 six emails do not establish that Plaintiffs’ do not permanently preserve all electronic data.

Exploring the uncertainty created by this testimony and missing emails, however, is the

28

1 (parenthetical and citations omitted). Further, because two of the significant events

2 implicating Topic 4 (i.e., MedImpact’s January 27, 2022 response and Brown’s March 3,

3 2022 declaration) occurred after the fact discovery cut-off, the Court finds Defendants’

4 have demonstrated good cause to reopen discovery for the limited purpose of taking this

5 deposition.

6 The Court, however, finds “the sources of electronic data from which MedImpact

7 searched and collected documents in connection with the above captioned case” too broad

8 and too attenuated from the narrower issues raised by Plaintiffs’ discovery responses

9 discussed above. Accordingly, the Court limits Topic 4 as follows:

10

MedImpact’s retention and preservation of electronic data,

11 including how MedImpact retains and preserves electronic data;

the ability of MedImpact employees to delete, modify or remove

12

electronic data; and any restrictions implemented by MedImpact

13 or imposed upon MedImpact employees to restrict their ability to

delete, modify or remove electronic data.

14

15 B. Litigation Holds

16 The parties do not dispute that litigation holds are generally protected from

17 discovery. See Dkt. Nos. 533-1 at 11; 546 at 12–13. Defendants, however, contend the late

18 distribution of Plaintiffs’ litigation hold and the uncertainty over Plaintiffs’ ESI retention

19 waives this protection. Dkt. No. 533-1 at 12–13.

20 Litigation holds, “if prepared by counsel and directed to the client, are protected by

21 the attorney-client privilege.” Shenwick v. Twitter, Inc., No. 16-cv-05314-JST-SK, 2018

22 WL 833085, at *4 (N.D. Cal. Feb. 7, 2018). In certain cases, courts have held a

23 “preliminary showing of spoliation” can overcome the privilege attached to litigation

24 holds. See, e.g., City of Colton v. Am. Promotional Events, Inc., No. 09-cv-1864-PSG-

25 SSx, 2011 WL 13223880, at *2 (C.D. Cal. Nov. 22, 2011) (“Even if particular litigation

26 hold communications are privileged, the court has an inherent power to order their

27 production in connection with a spoliation claim.”).

28

1 Defendants have not made a preliminary showing of spoilation here. Although

2 Plaintiffs concede six emails are not contained in their database, there are possible benign

3 explanations for this, and the content of these emails are contained within larger email

4 chains already in Defendants’ possession. Dkt. No. 532-7 at 3 (sealed). In addition, the

5 contents of the litigation holds will shed no light on the timing of the holds themselves or

6 on the separate and larger issues surrounding Plaintiffs’ ESI retention policies and

7 practices. The Court, therefore, denies Defendants’ Motion to compel Plaintiffs’

8 unredacted litigation holds.

9 IV. MOTION TO SEAL

10 Defendants filed a Motion to File Under Seal. Dkt. No. 531. Defendants request the

11 Court seal the documents lodged at Dkt. No. 532 (Motion to Compel Rule 30(b)(6)

12 Discovery and exhibits provided in support of the Motion) because they “include[ ] a

13 declaration, portions of deposition transcripts, and a letter involving sensitive technical and

14 business information.” Dkt. No. 531 at 3. Defendants filed a redacted pleading that omits

15 the information in question. Dkt. No. 533. Good cause appearing, the Court GRANTS the

16 Motion to File Under Seal and directs the Clerk of Court to file the documents lodged at

17 Dkt. No. 532 under seal. See Kamakana v. City & Cnty. of Honolulu, 447 F.3d 1172, 1180

18 (9th Cir. 2006) (“[A] particularized showing under the ‘good cause’ standard of Rule 26(c)

19 will suffice to warrant preserving the secrecy of sealed discovery material attached to non-

20 dispositive motions.”) (internal quotations, citations, and edits omitted).

21 / /

22 / /

23 / /

24 / /

25 / /

26 / /

27 / /

28 / /

I Vv. CONCLUSION

2 Based on the foregoing, Defendants’ Motion to Compel is granted in part and denied

3 ||in part as follows: (1) Plaintiffs must produce a witness(es) to testify for a further Rule

4 30(b)(6) deposition on Defendants’ noticed deposition Topic 4 in accordance with the

5 || limitations described herein; (2) the deposition must take place on or before June 15, 2022;

6 || and (3) Defendants’ request for Plaintiffs’ unredacted litigation holds is denied. The Clerk

7 || must file documents lodged at Dkt. No. 532 UNDER SEAL.

8 IT IS SO ORDERED.

9 Dated: May 26, 2022 —

10 wdc oTon

11 Honorable Daniel E. Butcher

United States Magistrate Judge

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.